<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01150019</url>
  </required_header>
  <id_info>
    <org_study_id>PET_Resistin</org_study_id>
    <nct_id>NCT01150019</nct_id>
  </id_info>
  <brief_title>Correlation Between Circulating Resistin and Vascular Inflammation Measured by 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) (18FDG-PET)</brief_title>
  <official_title>Correlation Between Circulating Resistin and Vascular Inflammation Measured by 18FDG-PET in Obese Person</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vascular inflammation is a key factor in both the pathogenesis and outcome of
      atherosclerosis.Resistin was shown to induce vascular endothelial dysfunction and vascular
      smooth muscle cell proliferation.

      18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising tool for
      identifying and quantifying vascular inflammation within atherosclerotic plaques.Therefore,
      the purpose of the study is to demonstrate the correlation between circulating resistin and
      vascular inflammation detected by 18FDG-PET in obese persons.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vascular inflammation in carotid arterial wall represented as the target-to-background ratio (TBR) using FDG-PET</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Circulating serum adiponectin levels</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>carotid intima-media thickness levels measured using ultrasonography</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Circulating serum resistin levels</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">120</enrollment>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Obese Group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Non Obese Group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cross sectional study</intervention_name>
    <description>This is not intervention study. The purpose of the study is to examine the relationship between various adipokine levels and PET imaging at the cross section setting</description>
    <arm_group_label>Obese Group</arm_group_label>
    <arm_group_label>Non Obese Group</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma, whole blood, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy participats who underwent a medical health check in the health promotion center in
        Korea Guro University
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers for visiting routine medical check in our clinic

        Exclusion Criteria:

          -  History of cardiovascular disease (myocardial infarction, unstable angina,stroke, or
             cardiovascular revascularization)

          -  Diabetes

          -  Hypertension

          -  Malignancy

          -  Severe renal or hepatic disease

          -  Subjects taking medications that might affect inflammation such as non-steroidal
             anti-inflammatory drugs (NSAIDs) and statin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyung Mook Choi, MD.PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hae Yoon Choi</name>
      <address>
        <city>Seoul</city>
        <zip>152-703</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2010</study_first_submitted>
  <study_first_submitted_qc>June 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2010</study_first_posted>
  <last_update_submitted>July 7, 2010</last_update_submitted>
  <last_update_submitted_qc>July 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Kyung Mook Choi</name_title>
    <organization>Korea University</organization>
  </responsible_party>
  <keyword>atherosclerosis</keyword>
  <keyword>vascular inflammation</keyword>
  <keyword>resistin</keyword>
  <keyword>adiponectin</keyword>
  <keyword>18FDG-PET</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorodeoxyglucose F18</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

